Treatmybrand


a Kainjoo SA Venture
Ch. du Vernay 14a
1196 Gland
+41.21.561.34.96
[email protected]

Support


Monday to Friday
8AM to 8PM
[email protected]
Back

Intellia Therapeutics Faces Critical Challenge Over CRISPR Drug Safety Concerns

Intellia Therapeutics is confronting a major survival challenge after its CRISPR gene-editing treatment was linked to severe, potentially fatal liver toxicity, raising serious safety concerns.

Stat
Stat